Attitudes to atypical and conventional antipsychotic drug treatment in clinicians participating in the cutlass study

Author： Lloyd Helen   Markwick Alison   Page Eleanor   Lewis Shôn   Barnes Thomas  

Publisher： Ashgate Publishing Ltd

ISSN： 1365-1501

Source： International Journal of Psychiatry in Clinical Practice, Vol.9, Iss.1, 2005-03, pp. : 35-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neurocognitive effects of atypical and conventional antipsychotic drugs in schizophrenia: A naturalistic 6-month follow-up study

By Wittorf Andreas  

Archives of Clinical Neuropsychology, Vol. 23, Iss. 3, 2008-05 ,pp. : 271-282

Oxford University Press

Access to resources Recommend Favorite

Antipsychotic treatment in schizophrenia: atypical options and NICE guidance

By Mortimer A.M.  

European Psychiatry, Vol. 18, Iss. 5, 2003-08 ,pp. : 209-219

Elsevier

Access to resources Recommend Favorite

On the mechanisms of action of atypical antipsychotic drugs. An experimental study

By Hertel Peter  

Nordic Journal of Psychiatry, Vol. 53, Iss. 6, 1999-12 ,pp. : 473-474

Informa Healthcare

Access to resources Recommend Favorite

Glucose Metabolism in Relation to Schizophrenia and Antipsychotic Drug Treatment

By Dwyer D.S.  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 13, Iss. 2, 2001-06 ,pp. : 103-113

Springer Publishing Company

Access to resources Recommend Favorite

Tardive dyskinesia caused by the atypical antipsychotic risperidone and cured by the use of another drug of the same class, olanzapine

By Ipekci S.   Birsoz S.  

European Psychiatry, Vol. 16, Iss. 4, 2001-06 ,pp. : 259-260

Elsevier

Access to resources Recommend Favorite